[Combination therapy with Anastrozole and 5'-DFUR as a treatment for metastatic breast cancer].

Author: FuchimotoSadanori, InagakiMasaru, MiyoshiKazuya, NakagawaTomio, OhsakiToshihide, OhtsukaShinya, YumuraMasahito

Paper Details 
Original Abstract of the Article :
For metastatic breast cancer patients who have hormone receptor-positive tumors, hormonal therapy aiming at optimal palliation and prolongation of life is the initial treatment of choice. To enhance the effect of hormonal monotherapy, a combination therapy with Anastrozole 1 mg po and 5'-DFUR 800 mg...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/15508445

データ提供:米国国立医学図書館(NLM)

Combination Therapy with Anastrozole and 5'-DFUR as a Treatment for Metastatic Breast Cancer

The field of [oncology] is constantly seeking effective and safe treatments for [metastatic breast cancer]. This research explores the potential of a [combination therapy] using anastrozole and 5'-DFUR in patients with metastatic breast cancer. The authors investigated the efficacy and safety of this combination therapy in a [clinical trial]. The findings suggest that this combination therapy demonstrates promising response rates with minimal side effects.

Anastrozole and 5'-DFUR: A Promising Combination for Metastatic Breast Cancer

This study presents encouraging results for a combination therapy using anastrozole and 5'-DFUR in patients with metastatic breast cancer. The researchers found a significant response rate with minimal side effects, suggesting that this combination may offer a valuable treatment option for this challenging disease.

Personalized Cancer Treatment: Balancing Efficacy and Safety

This research underscores the importance of personalized cancer treatment, seeking therapies that balance efficacy with minimal side effects. The combination therapy of anastrozole and 5'-DFUR appears to offer a promising approach, but further research is needed to confirm its long-term benefits and optimal use. Just as a camel navigates the desert by choosing the safest and most efficient route, cancer treatment requires careful consideration of individual patient needs and the potential benefits and risks of various therapeutic options.

Dr.Camel's Conclusion

This study provides a promising glimpse into the potential of combination therapy with anastrozole and 5'-DFUR for metastatic breast cancer. The findings suggest that this combination may offer a valuable treatment option with a favorable safety profile. It's a reminder that, just like a camel adapts its journey to the unique challenges of the desert, cancer treatment requires ongoing exploration and innovation to find the most effective and safe solutions for patients.

Date :
  1. Date Completed 2004-11-08
  2. Date Revised 2018-11-30
Further Info :

Pubmed ID

15508445

DOI: Digital Object Identifier

15508445

Related Literature

SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.